A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

NCT06816264 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment of Lipoprotein Disorder

Interventions

DRUG: HRS-5346
DRUG: Placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.